Jin Medical International LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Jin Medical International Ltd. reports a significant dilution in beneficial ownership percentage for key stakeholders following a substantial share issuance.
NASDAQ
Jin Medical International Ltd. announces a strategic share restructuring involving key shareholder Erqi Wang to maintain voting control amidst a recapitalization and acquisition.